Last updated: July 29, 2025
Introduction
Patent KR20140056396 pertains to a pharmaceutical invention filed in South Korea, designed to secure exclusive rights related to a specific drug formulation or therapeutic method. Its scope, claims, and the patent landscape delineate the Innovation's breadth, enforceability, and market potential within South Korea. A comprehensive understanding of this patent informs stakeholders about possible competitive advantages, licensing opportunities, and patent validity challenges.
Patent Overview and Context
Patent KR20140056396 was filed with the Korean Intellectual Property Office (KIPO). The patent, granted or pending, relates to a novel drug candidate or therapeutic approach, often originating from industry or academic innovation. The precise scope depends on the claims section, which defines the boundaries of the inventive subject matter.
The relevant patent landscape encompasses similar patents in South Korea, international patent applications, and related therapeutic or formulation patents. Analyzing these helps identify overlapping rights, potential for patent thickets, or freedom-to-operate issues in the Korean pharmaceutical market.
Scope of the Patent
1. Subject Matter
The patent's scope generally covers:
- Compound claims: Specific chemical entities or derivatives designed for therapeutic use.
- Formulation claims: Innovative compositions, excipients, or delivery systems that optimize efficacy or stability.
- Method claims: Therapeutic methods, dosing regimens, or treatment protocols.
- Use claims: Specific indications for the drug's application.
In the case of KR20140056396, the patent’s strongest claims likely focus on a novel chemical compound with improved pharmacokinetics or reduced side effects, or an inventive formulation that enhances bioavailability.
2. Claims Scope
South Korean patents typically include independent and dependent claims:
- Independent Claims: Broader scope, defining the core invention (e.g., a chemical compound or a method of treatment).
- Dependent Claims: Narrower, elaborating specific embodiments or features.
The scope of independent claims directly influences patent strength and market exclusivity. If the patent claims a specific compound, it prevents others from manufacturing, using, or selling the identical compound. If claims cover a therapeutic use or formulation, they may be more vulnerable to prior art challenges, unless the claims are narrowly tailored.
3. Limitations and Exclusions
The claims are constrained by the prior art, novelty, and inventive step requirements. For instance, if earlier patents disclose similar chemical structures or therapeutic methods, the patent must specify distinctive features to maintain scope.
Claims Analysis
1. Composition Claims
Typically, composition claims in pharmaceutical patents specify a combination of active ingredients, excipients, and dosing forms. For KR20140056396, claims likely detail:
- A specific chemical compound with defined structural features.
- Stability or purity thresholds.
- Concentration ranges.
Broader claims cover the compound itself, while narrower claims specify its salts, esters, or derivatives.
2. Method of Use Claims
Method claims may specify:
- The therapeutic method of administering the compound.
- Dosage and frequency parameters.
- Specific indications, such as neurodegenerative diseases or cancer.
These claims underpin the patent's utility and can enhance market exclusivity for treatment protocols.
3. Formulation and Delivery Claims
Innovative delivery systems, such as controlled-release formulations or targeted delivery mechanisms, are protected by formulation claims. If the patent introduces a novel delivery device or method that enhances drug bioavailability, these claims significantly expand scope.
4. Inventive Step and Novelty
The claims are evaluated against prior art, including other Korean patents, patent applications filed internationally, and scientific literature. The novelty hinges on unique structural features or therapeutic applications not disclosed previously. Inventive step is demonstrated if the claimed invention is non-obvious to a person skilled in the art.
Patent Landscape in South Korea
1. Comparative Patent Analysis
The patent landscape in South Korea reveals a dense cluster of patents relating to similar chemical classes, particularly within the domain of kinase inhibitors, monoclonal antibodies, or other targeted therapies. For instance:
- Related patents filed by Korean bio-pharma companies or international corporations with Korea-specific filings.
- Similar patents on structural analogs or combinational therapies.
This landscape indicates a competitive environment, necessitating clear and distinctive claims for patent strength.
2. Patent Family and Priority Data
KR20140056396 likely has a family spanning multiple jurisdictions. Its priority date (possibly from earlier PCT filings or applications in other jurisdictions) affects the validity and potential for enforcement. Cross-referenced patents and family members influence freedom-to-operate considerations.
3. Patent Challenges and Litigation
In South Korea, patent litigation or oppositions may target broad or overlapping claims. Understanding prior art references and legal standards in Korea guides patent defensibility.
Patent Strategy Considerations
- Defensibility: Narrow, well-drafted claims with fiat scope around novel features resist invalidation.
- Freedom to Operate (FTO): A landscape analysis helps identify potential infringement risks.
- Lifecycle Management: Supplementary patents on formulations, methods, or specific indications extend commercial exclusivity.
- Patent Maintenance: Ensuring timely renewal and strategic divisional filings optimize patent estate value.
Conclusion
KR20140056396's scope encapsulates a targeted chemical compound, its method of therapeutic use, and potentially innovative formulations, subject to the claims' breadth and clarity. It functions within a complex patent landscape characterized by overlapping rights, emphasizing the necessity for strategic claim drafting, vigilant landscape monitoring, and comprehensive FTO analyses. Its strength ultimately depends on how effectively the claims delineate the inventive contribution relative to prior art, and how the patent estate is managed to sustain competitive advantage in South Korea’s dynamic pharmaceutical market.
Key Takeaways
- The patent’s scope fundamentally depends on the specificity and breadth of its independent claims, influencing enforceability and market exclusivity.
- A detailed landscape analysis reveals competing patents in the same therapeutic or chemical space, impacting strategic positioning.
- Well-defined claims, coupled with strong inventive and novelty disclosures, establish robust IP protection.
- Continuous monitoring of patent filings, disputes, and legal developments in South Korea ensures sustained freedom-to-operate.
- Strategic patent lifecycle management, including supplementary and divisional applications, optimizes portfolio strength.
Frequently Asked Questions (FAQs)
1. What is the primary focus of patent KR20140056396?
It generally covers a novel chemical compound, a therapeutic method, or an innovative drug formulation, depending on its claims.
2. How does the scope of claims influence a patent’s enforceability?
Broader independent claims provide wider protection but are more susceptible to invalidation if prior art exists; narrower claims are easier to defend but offer limited exclusivity.
3. What challenges exist within the South Korean patent landscape for pharmaceuticals?
Overlapping patents, patent thickets, and prior art are common hurdles; strategic claim drafting and comprehensive landscape surveys mitigate these risks.
4. How can stakeholders ensure the strength of their patent rights?
By focusing on inventive, non-obvious features, maintaining clear claim boundaries, and continuously monitoring related patents and legal developments.
5. What role do patent families and priority dates play?
They bolster the patent’s validity, prevent third-party filings in key jurisdictions, and influence global patent protection strategies.
References
- Korean Intellectual Property Office (KIPO) official database.
- Patent document KR20140056396 and related filings.
- Patent landscaping reports on South Korean pharmaceutical patents.
- South Korean patent law and examination guidelines.
